The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Interim analysis.
Oscar Juan Vidal
No relevant relationships to disclose
Sergio Vazquez-Estevez
No relevant relationships to disclose
Vicente Giner
No relevant relationships to disclose
Joaquin Casal Rubio
No relevant relationships to disclose
Jose-luis Firvida
No relevant relationships to disclose
Francisco Aparisi
No relevant relationships to disclose
José Muñoz-Langa
No relevant relationships to disclose
Jose Garcia Sanchez
No relevant relationships to disclose
Regina Girones
No relevant relationships to disclose
Francisco Javier Perez
No relevant relationships to disclose
Alfredo Sanchez-Hernandez
No relevant relationships to disclose